Lilly’s Mirikizumab Superior to Cosentyx in a Phase 3 Study for Patients with Moderate...
Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the...
SGS to provide analytical testing for AstraZenecas Covid-19 vaccine
SGS will provide its services to support the development of AstraZeneca’s Covid-19 vaccine candidate –...
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC)...
Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA in Patients Treated...
Biogen Inc announced it plans to initiate a global Phase 4 clinical study, RESPOND, to...
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced...
Moderna’s COVID-19 Vaccine Soon to Enter Phase 3 Trials as Phase 1 Shows Positive...
Moderna, an American biotech company announced on July 14 that its COVID-19 vaccine candidate is...
ACTC, Eisai & Biogen announce initiation of new phase III clinical study of BAN2401...
The Alzheimer's Clinical Trials Consortium , Eisai Co., Ltd and Biogen Inc announced that a...
Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies
Orgenesis Inc., a pioneering global biotech company committed to accelerating commercialization and transforming the delivery...
Byondis Investigational Antibody-Drug Conjugate SYD985 Selected for I-SPY 2 TRIAL in Early-Stage Breast Cancer
Byondis B.V. announced that Quantum Leap Healthcare Collaborative selected the company’s investigational antibody-drug conjugate (ADC)...
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates...
Pfizer Inc. and BioNTech SE announced that two of the companies’ four investigational vaccine candidates...
